Every week, Florida Medical Marijuana’s Office (OMMU) is part of the State Health Ministry, publishes data on the State Medical Cannabis program, including the calculation of the active patient, and updates for each operator. These data include number of dispenses and unit of unit each week. This is the fourteenth new Cannabis enterprises in Florida Medical Cannabis Market. On May 2024, May 2024, we published a newsletter about the state, offering readers Beware of FloridaA number of this article is based Update provided to 10/03 By the end of the end of 10/02. Readers who are interested in upcoming data can visit Ommu update pageA number
The patient’s growth has slowed down
The last time we refreshed in the Florida market in September and the annual growth of the patient’s calculation was 4.4% decreased by 4.3% after the last May last year. From March, the growth rate was collected a little, and it was again touched by the end of this last week from 10/02 to 4.6%. It has fallen a lot.
Although the number of patients is still growing, the growth is very low and significantly significantly a few years ago. The 926K patient represents 4% of the population of the state. The number of patients decreased before the possible legalization of adults, but recently increased at a new height.
The year ended about 895k patients and the growth rate was 3.5% since then. This works are underway for the annual growth of 4.6%, which exceeds 3.5% of 2024, but below the 11.0% increase in 2023.
Over the years, some program improvements have helped Florida residents of the Medical Cannabis, which now has a vessel flower and Swedes. Afterwards, the post-election epidemic population booms to help the patient’s growth. A year ago, the number of dispenses of 683 to 734 was registered. This is 7.5% growth, which is much faster than the growth of the medical cannabis’s patient is 4.6% since then. Looking at changes since the end of 2024, the open dispenser increased by 4.6%, and the patient’s calculation increased by about 3.5%.
Unit growth remains very strong
During the last week, the sale of medical cannabis products increased by 21.1% a year ago. The units of the floral flower were expanded by 14.6% after the end of 10/02/24. The increase in the unit remains higher than the acquisition of income and winning the patient. There are more shops, and the volume of the unit is growing.
We shared Florida’s income only by 1,4% to the beginning of a year, according to BDSA. This was then a record, but all historical data were reviewed by BDSA in September. The growth of April 2024 is now -40.8%, which seems to seem out of time. We reached BDSA, and they confirmed this income score, as the total number of 2021-2025 is now much lower. Looking at the revised data of 2025, the growth of Florida’s sales, as BDSA is predicted, the monthly annual growth is 6.8% (June). In Q3 it increased by 2.5% compared to the Q3 of 2024, and that 0.1% decreased in SeptemberThe growth of a number of patients and disponderable growth led to the growth of the unit, but the general sales only in Q3 was only marginal.
Florida MSOS is weak
We have warned the readers on May 17, 2024, in Blorida, as investors seemed too optimistic. Since then, the entire Cannabi market has spread, and the entire MSOS group is low, especially since the default of the adult’s ballotee’s initiative in November. All four Florida leaders have decreased significantly, despite the 10/09/25, especially the health of ayust, which made a big bet on the activities of the state.
The general sphere, measured by the NCV Global Cannabis stock index, last night, at 7.96, at 7.96, and the NCV American CANNABIS operator, which is now nine members and closed at 14.90. All Florida 4 have fallen over both. MSOS now has Curalef and Thutief by 47.1% of ETF decreased by 44.8%. Planet 13, which was acquired, which was forced by a large Florida player, decreased by 61.0%, which is better than four Florida leaders.
A year ago, many were waiting for Florida to legalize the cannabis for adult use, and operators expanded their dispensary calculation. While the majority of Florida’s voters have confirmed adult use, the means could not receive 60% of the required law. The year 2025 saw more dispensers, partially completed the planned plans for the failure of adult use. The market is fighting with slow growth of patients, open and competitive problems to raise dispenses (like sales sales). The result has been a flat income despite the growth of a strong unit.
Investors were disappointed that Florida voters did not pass the initiative to legalize adults, and they will most likely be pleased with a mature medical market that slows and becomes more competitive. Perhaps Florida will be legalized in 2026 for adult use, but from now on it has been a long time. Investors must be careful with the great Florida operators from our point of view. Although they have fallen significantly, they could fall more, because the market is deteriorating, especially the leader, which is located there, and the leader is in the state.
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Michigan Cannabis sales in January have sharply decreased compared to a year ago, as they decreased by 15.9% consecutively. At $226.8 million, sales decreased by 8.3 percent compared to last year.
The Michigan Cannabis Regulatory Agency breaks down sales by medical and adult use, with medical sales down 43.4% year over year to $0.4 million, down 1.6% sequentially, and adult use sales down 8.2% year-over-year to $226.4 million, up 15.9% sequentially.
The state breaks down sales by category and provides pricing details by category for both medical and adult;
For adults
Medical
As supply continues to expand, prices for adult flowers have plummeted. The average price of $945 per pound in January is up 1.5% sequentially from a record low and down 11.2% from a year ago.
Michigan hemp sales are expected to grow 82.1% to $1.79 billion in 2021, 27.9% to $2.29 billion in 2022, and 33.3% to $3.06 billion in 2023. billion The program should continue to expand going forward as supply becomes more affordable and distribution expands.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s 15-state monthly cannabis sales data.
In January, cannabis sales decreased sequentially by 3.1%. In this review, we break down the results by state, starting with the western markets and then ending with the eastern markets. Overall, the BDSA estimates sales in 15 markets totaled $2.07 billion in January, up 4.6 percent from a year earlier. BDSA updated its Illinois numbers after the state recently changed the way it counts sales.
Western markets
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In December, annual growth was negative in 4 states. Growth in each of these states fell in succession.
Eastern markets
BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. Annual growth in December ranged from -3.1% in Missouri to +37.6% in New York. Ohio began using adults in August, spurring growth. Note that Florida and Pennsylvania are medical markets only. On a daily basis, sequential gains declined in eight markets. Annual growth was negative in both markets and sharp in both states. We warned of a potential slowdown in Florida despite strong dispensary and unit volume growth due to competitive pressure.
For readers interested in a deeper look hemp markets in these fifteen states and more, including segmentation by additional product categories, brand and product details, longer history and segmentation by product attributes, learn how BDSA Solutions can give you access to actionable data and analytics.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Illinois released sales figures for two months on Friday. The last time it released the data in November, the state did a major review of historical sales after a long delay, and it was updated to October. The previous report was for Cannabis for adults in May. The November document explained that the lack of data was due to the Metrc transition. “Sales tracking features in Metrc help retailers more accurately and reliably report actual sales, including all discounts and promotions at checkout. A careful review of past data shows that some initial discount prices were collected in previous months.” Here is the updated data until the end of 2025.
Statewide adult cannabis sales rose 5.6% sequentially to $116.6 million in December, up 2.2% on the day. Year-on-year growth was -23.9%, a slight improvement from November’s -26.1% growth. Here is a chart of adult sales over time:
After growing 106% in 2021, 13% in 2022 and 5% in 2023, annual sales for adults are set to grow 5.4% to $1.72 billion in 2024. In 2025, they decreased by 12.5% to $1.51 billion, which was lower than the total in 2022.
There hasn’t been an update from the state on medical cannabis in a while. The state exempts the sale separately from its medical plan, and April issue showed that sales fell 1.6% sequentially to $19.7 million, down 13.2% year over year.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El